La cadena de opciones muestra datos clave de las opciones de acciones de Virax Biolabs Group a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Virax Biolabs Group..

Virax Biolabs Group (NASDAQ:VRAX) Bolsa, Cadena de Opciones

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AEMD

APCX

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

DALN

DSGN

ELAB

KULR

LITM

MESO

NVNI

PTPI

QNTM

SGMO

SLXN

VRAX

Acciones de Sangamo Therapeutics suben un 19,5% tras un nuevo acuerdo. Descubre los mayores ganadores y perdedores de hoy.

Acciones de Sangamo Therapeutics (SGMO) suben alrededor de un 20%; 20 acciones que se mueven en el premercado

Virax Biolabs Group Limited - Ordinary Shares

Virax Biolabs Group Ltd

Stocks didn't just stumble—they cratered. From April 3 to April 8, the S&amp;P 500 slid 12%, the Nasdaq Composite dropped 13%, and the Dow Jones Industrial Average fell 11% as investors digested President <a href="https://www.benzinga.com/personal-finance/25/03/44237846/trump-proposes-special-a-gold-card-for-wealthy-immigrants-that-costs-5-million-says-selling-enou">Donald Trump</a>'s sweeping "Liberation Day" tariffs.&nbsp;
After the rout, Trump stepped into the White House press briefing room on April 9 and paused most levies for 90 days.&nbsp;
One day later, commentator Ben Shapiro told listeners of "<a href="https://www.youtube.com/watch?v=XkXIE9R1N5E&amp;ab_channel=BenShapiro">The Ben Shapiro Show</a>" that the U‑turn had nothing to do with "4‑D chess." Instead, he said, "it was just people getting yippy and bond markets getting queasy."
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
</ul>
<h2 class="wp-block-heading">Tariff Roller Coaster Shakes Investors</h2>
Trump announced a 10% tariff on some imports and a hefty 145% tariff specifically on Chinese goods during a speech in Washington on April 2.
Those headline figures, paired with warnings from economists, fed the week‑long sell‑off <a href="https://www.businessinsider.com/trump-says-might-not-raise-tariffs-china-consumption-buying-2025-4">Business Insider</a> chronicled, while <a href="https://www.theguardian.com/us-news/2025/apr/16/trump-tariffs-will-send-global-trade-into-reverse-this-year-warns-wto">The Guardian</a> traced the China tariff to the administration's "America First" reset.
By April 8, bond traders were in full retreat. The 10‑year Treasury yield jumped to 4.26%, its sharpest three‑day climb since 1982, <a href="https://www.reuters.com/markets/rates-bonds/sudden-selloff-shakes-us-bond-market-2025-04-08/">Reuters</a> reported. Higher yields pushed up borrowing costs and amplified worries that tariff‑driven inflation would hit households already wrestling with rising prices.
Trending: How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.
<a href="https://www.wsj.com/livecoverage/stock-market-trump-tariffs-trade-war-04-09-25">The Wall Street Journal</a> reported within minutes, futures turned green, and by the closing bell the S&amp;P 500 had rebounded 9.5% while the Nasdaq soared 12.2%.
Shapiro replayed Trump's explanation—"people were getting yippy… bond markets getting queasy"—and laughed at claims of hidden strategy.
Institutional investors echoed the skepticism. On April 17, <a href="https://www.reuters.com/markets/rates-bonds/pimco-bearish-dollar-treasuries-us-safe-haven-status-wavers-2025-04-17/">PIMCO </a>said recent U.S. trade policies were weakening the dollar's traditional safe-haven appeal, prompting the firm to recommend trimming exposure to long-dated Treasuries in favor of global alternatives.
Global institutions also flagged risks. <a href="https://www.imf.org/en/News/Articles/2025/04/03/pr2587-statement-by-imf-managing-director-kristalina-georgieva#:~:text=%E2%80%9CWe%20are%20still%20assessing%20the,further%20harm%20the%20world%20economy.">International Monetary Fund</a> Managing Director Kristalina Georgieva said April 3 in a statement that newly announced U.S. tariffs "represent a significant risk to the global outlook at a time of sluggish growth," urging the U.S. and its trading partners to resolve tensions and avoid steps that could "further harm the world economy."
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a>
Academic models suggest the U.S. economy could face significant domestic costs from the <a href="https://www.benzinga.com/news/25/02/43759161/coca-cola-warns-trumps-tariffs-could-force-it-to-use-more-plastic-if-aluminium-cans-become-more-expensive-we-can-shift-to-pet">tariffs</a>. According to the <a href="https://budgetlab.yale.edu/research/fiscal-and-economic-effects-revised-april-9-tariffs">Yale Budget Lab</a>, Trump&#8217;s tariff package— combined with anticipated foreign retaliation — could reduce U.S. real GDP growth by 1.1 percentage points and result in 740,000 fewer payroll jobs by December.
Lawmakers sensed an opening. <a href="https://time.com/7276234/trump-tariff-insider-trading-schiff/">Time</a> reported April 10 that Sen. Adam Schiff (D‑CA) called for an insider‑trading probe to see whether anyone profited from advance knowledge of the pause, a step backed by several House Democrats .
Read Next:
<ul class="wp-block-list">
<li>Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

Ben Shapiro Says Trump's Tariff Reversal Wasn't 4D Chess – 'It Was Just People Getting Yippy And Bond Markets Getting Queasy'

Wells Fargo analyst Ike Boruchow maintains Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) with a Underweight and raises the price target from $300 to $315.

Price Target

Analyst Ratings

ULTA

Wells Fargo Maintains Underweight on Ulta Beauty, Raises Price Target to $315

JPMorgan's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) blockchain division, Kinexys, on Wednesday announced it has executed its first public transaction involving tokenized U.S. Treasury bonds on the Ondo Chain (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">ONDO</a>), marking a step forward in <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44456074/tokenization-will-merge-crypto-and-equities-bernstein">blockchain-based financial settlement</a>.
WHat Happened: The transaction used Ondo Finance's tokenized U.S. Treasuries Fund (OUSG) and was settled using Chainlink's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/link/usd">LINK</a>) cross-chain infrastructure.
It represents the first public use of JPMorgan's Kinexys Digital Payments platform to trade a tokenized asset on a public ledger.
The cross-chain transaction followed a Delivery versus Payment (DvP) model, exchanging the tokenized asset on the Ondo Chain with payment settlement processed on JPMorgan's Kinexys permissioned blockchain. 
Chainlink's offchain computing system, the Chainlink Runtime Environment (CRE), coordinated the atomic execution between the two networks.
The trade was conducted on the Ondo Chain testnet, a public Layer 1 chain developed for real-world asset tokenization. 
According to the firms involved, this marks Kinexys&#8217; first public integration beyond private blockchains and the first transaction ever settled on the Ondo Chain.
Also Read: <a href="https://www.benzinga.com/25/05/45403187/bernstein-identifies-three-key-drivers-behind-ethereums-recent-rally">3 Key Drivers Behind Ethereum&#8217;s 65% Rally: Bernstein</a>
Why It Matters: Unlike traditional settlement systems that rely on fragmented infrastructure and manual processes, this cross-chain setup allowed for simultaneous exchange of the asset and payment, aiming to reduce counterparty risk and improve settlement efficiency.
JPMorgan&#8217;s Kinexys unit claims to process more than $2 billion in transactions daily and has facilitated over $1.5 trillion in notional value since inception.
Chainlink's infrastructure enabled coordination of the settlement without needing trusted intermediaries, a feature the firm said is vital for enabling compliant, institutional-grade cross-chain activity.
Ondo Finance CEO Nathan Allman <a href="https://www.prnewswire.com/news-releases/chainlink-kinexys-by-jp-morgan-and-ondo-finance-team-up-to-bring-bank-payment-rails-to-tokenized-asset-markets-302455268.html">described</a> the test as a step toward scaling blockchain settlement for real-world financial assets.
The firms said the test established groundwork for future DvP transactions across both public and permissioned networks, with broader use cases expected in cross-border payments and tokenized asset markets.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45388118/bitcoin-taps-105-000-heres-when-it-could-hit-122-000">Bitcoin Taps $105,000: Here&#8217;s When It Could Hit $122,000</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$LINK

$ONDO

JPMorgan Completes First Public Trade Of Tokenized Treasuries

Wells Fargo analyst Ike Boruchow maintains TJX Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) with a Equal-Weight and raises the price target from $115 to $120.

Wells Fargo Maintains Equal-Weight on TJX Companies, Raises Price Target to $120

Welltower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) has outperformed the market over the past 10 years by 7.06% on an annualized basis producing an average annual return of 17.74%. Currently, Welltower has a market capitalization of $93.13 billion. 
Buying $1000 In WELL: If an investor had bought $1000 of WELL stock 10 years ago, it would be worth $5,118.72 today based on a price of $143.62 for WELL at the time of writing.
<h3>Welltower's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747232115_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

WELL

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

WIIM

ETON

Eton Pharmaceuticals shares are trading higher after the company reported better-than-expected Q1 financial results.

Wells Fargo analyst Ike Boruchow maintains Tapestry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) with a Overweight and raises the price target from $90 to $100.

Wells Fargo Maintains Overweight on Tapestry, Raises Price Target to $100

KinderCare Learning shares are trading lower after the company reported worse-than-expected Q1 sales results and cut its price target on the stock from $25 to $20.

Wells Fargo analyst Ike Boruchow maintains Signet Jewelers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) with a Equal-Weight and raises the price target from $60 to $70.

Wells Fargo Maintains Equal-Weight on Signet Jewelers, Raises Price Target to $70

FatPipe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATN#NASDAQ">FATN</a>), a pioneer in enterprise-class, application-aware, secure software-defined wide area network ("SD-WAN"), today announced the launch of its VeloCloud Replacement Program, a strategic initiative designed to help enterprises seamlessly transition from legacy VeloCloud SD-WAN deployments to FatPipe's next-generation, high-performance, highly secure SD-WAN platform.
With the recent changes in the SD-WAN landscape and evolving enterprise networking requirements, many organizations are seeking more flexible, secure, and cost-effective alternatives to existing solutions. This conversion opportunity represents a strategic growth lever for FatPipe, targeting legacy SD-WAN deployments worldwide. As organizations reevaluate their infrastructure, FatPipe's program aims to expand its footprint in the SD-WAN market expected to surpass $7 billion by 2027. The program is designed to not only drive new customer acquisition but also enhance FatPipe's recurring revenue through managed services and long-term software licensing.
FatPipe's VeloCloud Replacement Program offers a compelling upgrade path, providing customers with:
<ul>
<li>Zero-Cost Migration Assistance: A fully managed onboarding and transition plan, minimizing disruption to business operations. &nbsp;</li>
<li>Trade-In Discounts: Special pricing and trade-in credits for existing VeloCloud hardware and licenses. &nbsp;</li>
<li>Advanced SD-WAN Features: Superior application-aware routing, multi-line redundancy, edge security, and built-in single-stack cybersecurity. &nbsp;</li>
<li>Multi-Cloud Connectivity: Native support for all major public cloud providers including AWS, Azure, and Google Cloud. &nbsp;</li>
<li>Enhanced Security: Integrated firewall and cybersecurity, encryption, and compliance-ready architecture. &nbsp;</li>
<li>Proven ROI: Reduced network costs and improved application performance. &nbsp;</li>
<li>Managed and co-managed Network and cybersecurity monitoring.</li>
</ul>

FATN

FatPipe Launches VMware VeloCloud Replacement Program To Help Enterprises Upgrade To Advanced SD-WAN Solutions; Sales Growth To Be Funded With IPO Proceeds And Internally Generated Funds

NPCE

Neuropace shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance.

WALD

Waldencast shares are trading lower after the company reported a year-over-year decrease in Q1 sales results.

Morgan Stanley analyst Vikram Purohit downgrades Halozyme Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HALO#NASDAQ">HALO</a>) from Overweight to Equal-Weight and lowers the price target from $73 to $62.

Downgrades

HALO

Morgan Stanley Downgrades Halozyme Therapeutics to Equal-Weight, Lowers Price Target to $62

Wells Fargo analyst Ike Boruchow maintains Ross Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) with a Overweight and raises the price target from $150 to $155.

ROST

Wells Fargo Maintains Overweight on Ross Stores, Raises Price Target to $155

AFRM

Affirm shares are trading higher after the company was named the pay-over-time provider for Costco.com in the US.

WBTN

WEBTOON Entertainment shares are trading lower. The company reported Q1 financial results.

In the spring of 2025, two major geopolitical conflicts escalated: intensified fighting in Yemen in the Middle East and rising tensions between India and Pakistan in South Asia. While these conflicts remain localized, global markets no longer categorize the world into &#8220;hot spots&#8221; and &#8220;safe havens&#8221;. Every military incident is now perceived as a signal of systemic risk, influencing investor behavior, currency exchange rates- such as the strengthening U.S. dollar and commodity prices, with gold emerging as a key safe-haven asset.
This shift in perspective is well-founded. In today's interconnected economy, trust in stability has become one of the rarest &#8220;assets.&#8221; Markets respond to local conflicts almost instantly, turning them into global macroeconomic drivers.
<h2 class="wp-block-heading">Middle East and Asia: Catalysts for Gold's Price Surge?</h2>
Global investors view the escalation in Yemen as a systemic risk, prompting a shift toward safe-haven assets-most notably, gold. Since early May 2025, gold prices have climbed from 3,200 to nearly 3,450 US dollar per ounce, though they haven't yet breached the April peak of almost $3,500. This renewed focus on gold stems not only from fears of conflict escalation, but also from a broader strategic shift in investment behavior. With the oil market showing little reaction to geopolitical developments-Brent crude has hovered between $60 and $67 since April-gold has emerged as a primary gauge of rising anxiety and eroding confidence in global stability.
According to the <a href="https://www.gold.org/goldhub/research/gold-demand-trends/gold-demand-trends-q1-2025">World Gold Council</a>, global gold demand in Q1 2025 rose 16% year-over-year to 1,310 tonnes, with investment demand surging by 170% over the same period. Gold-backed exchange-traded funds (ETFs) have seen inflows reach their highest levels since 2022, totaling 226.5 tonnes. Both institutional investors, such as pension and insurance funds in the U.S. and Europe, and retail investors are hedging against currency and equity market volatility. However, a reversal emerged in early May: ETF holdings dropped by 1.6 tonnes as of May 2, with a further decline of over 18 tonnes in the prior two weeks-the largest outflow since November 2024. This pullback likely reflects profit-taking after the recent rally and hesitation near the $3,500 &#8220;psychological ceiling.&#8221;
Gold remains a sensitive barometer of global unease, yet investors are acting with greater deliberation, favoring strategic moves over knee-jerk reactions. The recent dip suggests a period of reassessment-some are securing gains, while others see it as a buying opportunity. This reinforces gold's enduring role as a protective asset, increasingly utilized within a calculated framework rather than as a panic-driven choice.
<h2 class="wp-block-heading">Currency Markets: Short-Term Swings and Long-Term Trends</h2>
Amid a global flight from risk, the U.S. dollar has gained strength. Its resilience against currencies like the Japanese yen, euro, and British pound is bolstered by the Federal Reserve's recent decision to hold interest rates steady, with officials indicating no cuts are expected before early 2026. Such policy stance enhances the dollar's appeal, particularly as uncertainty grips global markets.
Further supporting the dollar, President Donald Trump's efforts to secure a trade deal with the U.K. and address tariff disputes with China have solidified its status as a &#8220;currency of trust&#8221; among investors, even as concerns about a potential U.S. recession linger.
Shortly, the dollar's robustness reflects the Fed's steady monetary policy and a measured market response to external pressures. While localized conflicts fuel uncertainty, the dollar continues to anchor investor confidence.
<h2 class="wp-block-heading">From Yield to Preservation: Investor Behavior in a Turbulent Era</h2>
Geopolitical instability, including conflicts in Yemen and South Asia, is reshaping global markets, compelling investors to rethink their strategies. Capital is increasingly flowing into assets that shield against risk, such as gold and the dollar.
Gold's status as a &#8220;safe-haven&#8221; asset endures, though its recent price movements indicate a shift toward more deliberate investment decisions, signaling a decline in outright panic. The dollar's sustained strength against major currencies underscores growing demand for &#8220;hard&#8221; currencies backed by predictable policies.
Today, every local conflict weaves itself into the global economic narrative: fears of escalation shape expectations, which drive investor behavior and asset shifts. Geopolitics is no longer mere background noise-it's a structural force in global macroeconomics.
In such kind of evolving reality, investors are abandoning the pursuit of maximum returns in favor of sustainability and capital preservation. The market is no longer asking: "where to make money" &#8211; it's looking for an answer to the question: "what will survive the next shock".

Long Ideas

Commodities

Politics

Forex

Opinion

Adapting to an Unstable World: Gold, Dollar, and Investor Strategies

HYLN

Hyliion Holdings shares are trading lower after the company reported worse-than-expected Q1 financial results.

Wells Fargo analyst Ike Boruchow maintains Ralph Lauren (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>) with a Overweight and raises the price target from $240 to $275.

Wells Fargo Maintains Overweight on Ralph Lauren, Raises Price Target to $275

ETOR

Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Press Releases

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Contracts

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Comments

Virax Biolabs Group

Virax Biolabs Group (VRAX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL